Abstract
Spinal muscular atrophy (SMA) is a neurodegenerative disease characterized by progressive motor neuron loss and caused by mutations inSMN1(Survival Motor Neuron 1). The disease severity inversely correlates with the copy number ofSMN2,a duplicated gene that is nearly identical toSMN1.We have delineated a mechanism of transcriptional regulation in theSMN2locus. A previously uncharacterized long noncoding RNA (lncRNA),SMN-antisense 1(SMN-AS1), repressesSMN2expression by recruiting the Polycomb Repressive Complex 2 (PRC2) to its locus. Chemically modified oligonucleotides that disrupt the interaction betweenSMN-AS1and PRC2 inhibit the recruitment of PRC2 and increaseSMN2expression in primary neuronal cultures. Our approach comprises a gene-up-regulation technology that leverages interactions between lncRNA and PRC2. Our data provide proof-of-concept that this technology can be used to treat disease caused by epigenetic silencing of specific loci.
Publisher
Proceedings of the National Academy of Sciences
Cited by
74 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献